These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20136034)

  • 21. Efficacy of icodextrin in automated peritoneal dialysis patients.
    Tintillier M; Goffin E
    Am J Kidney Dis; 2002 Aug; 40(2):435. PubMed ID: 12148122
    [No Abstract]   [Full Text] [Related]  

  • 22. Decreased in vitro formation of AGEs with extraneal solution compared to dextrose-containing peritoneal dialysis solutions.
    Barre DE; Chen C; Cooker L; Moberly JB
    Adv Perit Dial; 1999; 15():12-6. PubMed ID: 10682064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sterile peritonitis due to icodextrin: experience from a Canadian center.
    Poulopoulos V; Lam L; Cugelman A
    Perit Dial Int; 2004; 24(1):88-9. PubMed ID: 15104348
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical effects of a peritoneal dialysis regimen low in glucose in new peritoneal dialysis patients: a randomized crossover study.
    le Poole CY; van Ittersum FJ; Weijmer MC; Valentijn RM; ter Wee PM
    Adv Perit Dial; 2004; 20():170-6. PubMed ID: 15384821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adept (Icodextrin 4%): a tale of caution.
    Saedon M; Borowski DW; Natu S; Hennessy C; Tabaqchali MA
    Colorectal Dis; 2010 Apr; 12(4):384-6. PubMed ID: 19604287
    [No Abstract]   [Full Text] [Related]  

  • 26. Hypoglycemic coma in a diabetic patient on peritoneal dialysis due to interference of icodextrin metabolites with capillary blood glucose measurements.
    Disse E; Thivolet C
    Diabetes Care; 2004 Sep; 27(9):2279. PubMed ID: 15333503
    [No Abstract]   [Full Text] [Related]  

  • 27. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis.
    Wolfson M; Piraino B; Hamburger RJ; Morton AR;
    Am J Kidney Dis; 2002 Nov; 40(5):1055-65. PubMed ID: 12407652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Icodextrin-induced peritonitis: study of five cases and comparison with bacterial peritonitis.
    Touré F; Lavaud S; Mohajer M; Lavaud F; Canivet E; Nguyen P; Chanard J; Rieu P
    Kidney Int; 2004 Feb; 65(2):654-60. PubMed ID: 14717938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inaccurate self-monitoring of blood glucose readings in patients on chronic ambulatory peritoneal dialysis with icodextrin.
    Pavlicek V; Garzoni D; Urech P; Brändle M
    Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):124-6. PubMed ID: 16636978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of icodextrin peritoneal dialysis solution on cell proliferation in vitro.
    Cooker LA; Choo CG; Luneburg P; Lamela J; Holmes CJ
    Adv Perit Dial; 1999; 15():17-20. PubMed ID: 10682065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe cutaneous hypersensitivity to icodextrin in a continuous ambulatory peritoneal dialysis patient.
    Lee SH; Park HC; Sim SR; Chung SJ; Kim KJ; Park WI; Hong SW; Ha SK
    J Nephrol; 2006; 19(5):673-6. PubMed ID: 17136700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of bicarbonate/lactate-buffered dialysate with a nighttime cycler, associated with a daytime dwell with icodextrin, may result in alkalosis in children.
    Vande Walle JG; Raes AM; Dehoorne J; Mauel R
    Adv Perit Dial; 2004; 20():222-5. PubMed ID: 15384831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new form of acute adverse reaction to icodextrin in a peritoneal dialysis patient.
    Del Rosso G; Di Liberato L; Perilli A; Cappelli P; Bonomini M
    Nephrol Dial Transplant; 2000 Jun; 15(6):927-8. PubMed ID: 10831669
    [No Abstract]   [Full Text] [Related]  

  • 34. Icodextrin - still a cause for concern with blood glucose monitoring in continuous ambulatory peritoneal dialysis patients with diabetes.
    Slim S; Griffiths MJ; Gama R
    Ann Clin Biochem; 2007 Mar; 44(Pt 2):196-7. PubMed ID: 17362588
    [No Abstract]   [Full Text] [Related]  

  • 35. Spurious hyperglycaemia and icodextrin in peritoneal dialysis fluid.
    Riley SG; Chess J; Donovan KL; Williams JD
    BMJ; 2003 Sep; 327(7415):608-9. PubMed ID: 12969932
    [No Abstract]   [Full Text] [Related]  

  • 36. [Influence of new dialysis solutions on clinical results in patients treated with peritoneal dialysis].
    Haag-Weber M
    Wien Klin Wochenschr; 2005; 117 Suppl 6():89-97. PubMed ID: 16437339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The utility of two daytime icodextrin exchanges to reduce dextrose exposure in automated peritoneal dialysis patients: a pilot study of nine patients.
    Gobin J; Fernando S; Santacroce S; Finkelstein FO
    Blood Purif; 2008; 26(3):279-83. PubMed ID: 18421212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions.
    Parikova A; Zweers MM; Struijk DG; Krediet RT
    Adv Perit Dial; 2003; 19():186-90. PubMed ID: 14763059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZ-induced diabetic rat model with partial nephrectomy.
    Nakao A; Nakao K; Takatori Y; Kojo S; Inoue J; Akagi S; Sugiyama H; Wada J; Makino H
    Nephrol Dial Transplant; 2010 May; 25(5):1479-88. PubMed ID: 19759273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exposure to the peptidoglycan contaminant in icodextrin may cause sensitization of the patient maintained on peritoneal dialysis.
    Povlsen JV; Ivarsen P; Jørgensen KA; Madsen S
    Perit Dial Int; 2003; 23(5):509-10. PubMed ID: 14604210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.